| Condition Brief | Condition Text | View |
|---|---|---|
| None | Candidemia | View |
| None | Mycoses | View |
| None | Fungal Infection | View |
| None | Fungemia | View |
| None | Invasive Candidiasis | View |
| None | Pneumocystis | View |
| None | Mold Infection | View |
| None | Invasive Fungal Disease | View |
| None | Prophylaxis of Invasive Fungal Infections | View |
| None | Aspergillus | View |
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Mycoses | View |
| None | Prophylaxis of Invasive Fungal Infections | View |
| None | Aspergillus | View |
| None | Candidiasis | View |
| None | Candidemia | View |
| None | Candidiasis, Invasive | View |
| None | Fungemia | View |
| None | Sepsis | View |
| None | Blood and Marrow Transplant (BMT) | View |
| None | Infection | View |
| None | Invasive Fungal Infections | View |
| None | Systemic Inflammatory Response Syndrome | View |
| None | Inflammation | View |
| None | Pathologic Processes | View |
| None | Fluconazole | View |
| None | Posaconazole | View |
| None | Caspofungin | View |
| None | Trimethoprim-sulfamethoxazole (TMP/SMX) | View |
| None | Echinocandins | View |
| None | Antifungal Agents | View |
| None | 14-alpha Demethylase Inhibitors | View |
| None | Cytochrome P-450 Enzyme Inhibitors | View |
| None | Enzyme Inhibitors | View |
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Steroid Synthesis Inhibitors | View |
| None | Physiological Effects of Drugs | View |
| None | Cytochrome P-450 CYP2C9 Inhibitors | View |
| None | Cytochrome P-450 CYP2C19 Inhibitors | View |
| None | Pneumocystis | View |
| None | Mold Infection | View |
| None | Rezafungin | View |
| None | Anti-Infective Agents | View |